Table 2 Values are numbers with percentages in parentheses, unless indicated otherwise
Variable name | Overall cohort (n = 187) |
|---|---|
Procedural features | |
 Prior use of intravenous tPA | 36 (19.3) |
 General anaesthesia | 147 (78.6) |
 Use of Solitaire retriever | 138 (73.8) |
No. of passes | |
  ≤ 1 | 70 (50.7) |
 2 | 38 (27.5) |
  ≥ 3 | 30 (21.7) |
 -arterial tPA or Urokinase | 43 (23.0) |
 Balloon angioplasty | 101 (54.0) |
 Stenting | 93 (49.7) |
 Onset to puncture time, median (IQR), hours | 7 (5–10) |
 Procedure time, median (IQR), hours | 1.5 (1–2) |
 Onset to recanalization time, median (IQR), hours | 8.5 (6–11) |
 Procedural complications | |
 Embolization in distal or new territory | 18 (9.6) |
 Arterial dissection | 6 (3.2) |
 Arterial perforation | 8 (4.3) |
 Target-vessel reocclusion | 17 (9.1) |
Outcome measures | |
 Successful recanalization (mTICI 2b-3) | 158 (84.5) |
 Complete recanalization (mTICI 3) | 126 (67.4) |
 Hemorrhagic transformation within 24 h | 29 (15.5) |
 SICH (ECASS III definition) within 24 h | 8 (4.3) |
 Functional independence (mRS 0–2) at 90 days | 68 (36.4) |
 Favorable outcome (mRS 0–3) at 90 days | 92 (49.2) |
 Mortality at 90 days | 38 (20.3) |